The largest database of trusted experimental protocols

One glo tox luciferase reporter and cell viability assay

Manufactured by Promega

The ONE-Glo™ + Tox Luciferase Reporter and Cell Viability Assay is a combined assay that measures both luciferase reporter activity and cell viability in a single well. The assay utilizes a luciferase reagent to quantify reporter gene expression and a proprietary cytotoxicity reagent to determine cell health.

Automatically generated - may contain errors

3 protocols using one glo tox luciferase reporter and cell viability assay

1

NPC1 Dependent Autophagy Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, the p62-fluc.Npc1+/+ and p62-fluc.Npc1−/− MEFs were plated into white 96 well plates (2 k cell/well with 100 μL media) and allowed to settle for 24 hours. Next, the MEFs were treated with 1 μg/ml doxycycline (Sigma-Aldrich 33429) for 24 hours before being washed off 3 times with PBS. Subsequently, the specified drug or a combination of drugs was dissolved in Opti-MEM (Thermo Fisher) and all of media was removed from cells and replaced with DSPE-PEG2k containing media and incubated for 24 hours. MEFs to be treated for 48 hours with the micelles were aspirated after 24 hours and fresh DSPE-PEG2k media was added for the final 24 hours. After 24 hours or 48 hours of drug treatment, MEFs were analyzed using ONE-Glo™ + Tox Luciferase Reporter and Cell Viability Assay (Promega) by following the manufacturer’s protocol.
+ Open protocol
+ Expand
2

High-Throughput Screening of PHOX2B 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
To perform the automated drug screening, 30–40,000 cells were grown in white multiwell plates, added with drugs, and analyzed 24 h later. As the screening of the PHOX2B 3′UTR was performed in this study for the first time, no positive or negative control was known. Therefore, while the PHOX2B promoter screening (promoter HTS) was conducted in duplicate and in the presence of positive/negative controls, to obtain the most reliable screening even in the absence of controls, the 3′UTR screening (3UTR HTS) was carried out in triplicate. Both the luminescence produced by the firefly luciferase gene and the fluorescence produced by protease-mediated activity on the glycylphenylalanyl-aminofluorocoumarin (GF-AFC) substrate in living cells were measured by using a two-step assay which yielded the double information in a single well (ONE-Glo + Tox Luciferase Reporter and Cell Viability Assay, Promega). Either parameters were measured by an automated microplate reader (GloMax® Promega) following an already set up procedure [14 (link)]. To avoid misleading results that might be ascribed to the effect of drugs on the regulatory regions upstream or downstream the renilla gene, in the 3UTR HTS, renilla firefly activity was not measured.
+ Open protocol
+ Expand
3

High-Throughput Cellular Screening for Epigenetic Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical screening was performed at the Center for High-throughput Phenomics, Genome Institute of Singapore (CHiP-GIS). Briefly, Jurkat cells stably transduced with the eGIMAP-luciferase construct were seeded in 384-well plates at 2,500 cells per well. After 24 hours, compounds from the Epigenetics 151 Library (151 compounds, 2 mM, duplicates), Anticancer Library (414 compounds, 1 mM, triplicates), and Spectrum Collection (2,396 compounds, 1
µM, triplicates), dimethyl sulfoxide (DMSO), and THZ1 (1 µM) were added using a liquid handling workstation. Five hours after incubation, cell viability (fluorescence) and enhancer activity (luminescence) were measured using the ONE-Glo+Tox Luciferase Reporter and Cell Viability Assay (Promega) using a microplate reader (Tecan). The readout was normalized among the replicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!